Search

everythinglearnresearchcommunity

for

Search:↓

An 80-year-old man with COVID-19 also had constrictive pericarditis, possibly due to an autoimmune or immunoglobulin related disease, and improved after surgery.

Insulin resistance linked to obesity may increase COVID-19 severity.

Anabolic steroid users may face higher risk of severe COVID-19.

More clinical trials are needed to confirm if plant-based products can effectively treat COVID-19.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Sex hormones likely did not affect COVID-19 outcomes in South Korea.

Beau's lines on fingernails might indicate past severe COVID-19 and risk of reinfection.

The pandemic changed how often certain skin conditions were diagnosed.

Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

Vaccinated healthcare workers rarely experience long COVID-19 symptoms.

Severe COVID-19 increases the risk of hair loss.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

COVID-19 and its vaccine can cause skin issues, but most are minor and resolve on their own.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

COVID-19 infection and vaccination may trigger hair loss and rapid hair whitening.

The study suggests pandemic stress might worsen or trigger hair loss problems.

Standardized definitions and better methods are needed to accurately estimate long COVID-19 prevalence.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

Vaccination helps reduce long COVID symptoms in women with PCOS.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

Hair loss can happen after both mild and severe COVID-19, and areas with more COVID-19 cases may see more hair loss cases.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

COVID-19 vaccines caused mostly mild side effects in Bangladeshi medical students, with fewer issues after more doses.

People who had severe COVID-19 are more likely to experience hair loss.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

Dr. SKS hair booster serum effectively treats hair loss caused by COVID-19.